Earnings ·
CONMED Corporation reported second quarter 2026 financial results on July 29, 2026
CNMDCONMED Corp
CONMED Corporation reported second quarter 2026 financial results on July 29, 2026. Sales were $343.5 million, a 0.3% increase year-over-year, with organic constant currency sales rising 6.0%. Diluted earnings per share reached $0.77 (GAAP) and $1.38 (adjusted), both up significantly from the prior year period. The company updated its full-year 2026 guidance, raising net sales estimates to a range of $1,358 million to $1,373 million and adjusted diluted EPS to $4.48–$4.60. Operational highlights included the completion of strategic exits from gastroenterology product offerings and refinancing a portion of debt. CONMED Corporation operates in the medical device industry, manufacturing surgical equipment and instruments.